Why do some people with dementia experience a brief lucid period before death? (The Conversation)
Clinicians should outline uncertainties about potential risks like brain volume loss associated with anti-amyloid drugs when counseling Alzheimer’s patients considering treatment, researchers said. (JAMA)
The protein FLVCR2 appeared to be a blood-brain barrier choline transporter that’s responsible for most choline uptake into the brain. (Nature)
New-onset small fiber neuropathy after SARS-CoV-2 infection was responsive to treatment with intravenous immune globulin (IVIG), a case-control analysis showed. (Neurology)
Intravenous acyl-ghrelin was safe and potentially effective in improving neurologic outcome of people in a coma after cardiac arrest. (JAMA Neurology)
Repetitive transcranial magnetic stimulation improved cognition and increased functional connectivity between the hippocampus and precuneus in people with early Alzheimer’s disease, a small trial in Korea found. (JAMA Network Open)
Using 7-Tesla resting-state functional MRI data from the Human Connectome Project, researchers mapped a subcortical brain network that may integrate arousal and awareness in human consciousness. (Science Translational Medicine)
The FDA scheduled a June 10 advisory committee meeting to discuss investigational donanemab for early symptomatic Alzheimer’s disease, Eli Lilly said.
Focal nonmotor seizures in adolescents often were missed in the emergency department, a small study showed. (Neurology)
Medtronic said it received FDA approval for its Inceptiv closed-loop spinal cord stimulator to treat chronic pain.
The Harvard Business Review published a manager’s guide to long COVID at work.
Please enable JavaScript to view the